Polaryx Therapeutics, Inc. (PLYX)
2.09
-0.05
(-2.34%)
USD |
NASDAQ |
Sep 25, 16:00
Polaryx Therapeutics Price : 2.09 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 2.11 | 2.14 | 2.07 | 2.09 | 13407.00 |
| Sep 24, 2026 | 2.12 | 2.15 | 2.03 | 2.14 | 28138.00 |
| Sep 23, 2026 | 2.19 | 2.19 | 2.037 | 2.14 | 54571.00 |
| Sep 22, 2026 | 2.11 | 2.15 | 2.08 | 2.15 | 25190.00 |
| Sep 21, 2026 | 2.06 | 2.168 | 2.04 | 2.14 | 32086.00 |
| Sep 18, 2026 | 2.09 | 2.205 | 2.02 | 2.04 | 81508.00 |
| Sep 17, 2026 | 2.06 | 2.14 | 2.05 | 2.14 | 27550.00 |
| Sep 16, 2026 | 2.041 | 2.157 | 2.02 | 2.03 | 28031.00 |
| Sep 15, 2026 | 2.059 | 2.06 | 1.98 | 2.045 | 17080.00 |
| Sep 14, 2026 | 2.00 | 2.04 | 1.97 | 2.02 | 25085.00 |
| Sep 11, 2026 | 2.00 | 2.088 | 2.00 | 2.01 | 14524.00 |
| Sep 10, 2026 | 2.08 | 2.08 | 1.99 | 1.99 | 17432.00 |
| Sep 09, 2026 | 2.08 | 2.12 | 2.01 | 2.08 | 23533.00 |
| Sep 08, 2026 | 1.98 | 2.04 | 1.97 | 2.02 | 14363.00 |
| Sep 04, 2026 | 2.00 | 2.05 | 1.90 | 2.00 | 39727.00 |
| Sep 03, 2026 | 2.05 | 2.072 | 1.981 | 1.99 | 21103.00 |
| Sep 02, 2026 | 2.00 | 2.07 | 1.97 | 2.04 | 32824.00 |
| Sep 01, 2026 | 2.01 | 2.05 | 1.93 | 1.98 | 87141.00 |
| Aug 31, 2026 | 2.10 | 2.115 | 1.99 | 2.01 | 41438.00 |
| Aug 28, 2026 | 2.11 | 2.138 | 1.97 | 2.06 | 86311.00 |
| Aug 27, 2026 | 2.09 | 2.16 | 2.04 | 2.11 | 67070.00 |
| Aug 26, 2026 | 2.10 | 2.10 | 1.97 | 2.09 | 113960.0 |
| Aug 25, 2026 | 1.90 | 2.10 | 1.90 | 1.99 | 107210.0 |
| Aug 24, 2026 | 2.08 | 2.103 | 1.85 | 1.87 | 286161.0 |
| Aug 21, 2026 | 2.14 | 2.15 | 2.03 | 2.07 | 108472.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.17 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 7.59 |
| Fulcrum Therapeutics, Inc. | 3.74 |
Price Related Metrics
| Price to Book Value | 9.523 |
| Earnings Yield | -6.90% |
| Market Cap | 104.18M |